Clincosm LogoSign in Get a demo

Hodgkin Lymphoma

Showing NaN - NaN of 24
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Reserve in Younger Newly Diagnosed Lymphomas

Active, not recruiting
  • Anaplastic Large Cell Lymphoma
  • +4 more
  • Laboratory Biomarker Analysis
  • Questionnaire Administration
  • Birmingham, Alabama
  • +106 more
Jan 11, 2023

Hodgkin Lymphoma Trial in Worldwide (brentuximab vedotin, doxorubicin, vinblastine)

Active, not recruiting
  • Hodgkin Lymphoma
  • brentuximab vedotin
  • +5 more
  • Fountain Valley, California
  • +75 more
Dec 2, 2022

Participated in Children's Oncology Group Studies

Recruiting
  • Acute Lymphoblastic Leukemia
  • +5 more
  • Assessment of Therapy Complications
  • Questionnaire Administration
  • Birmingham, Alabama
  • +163 more
Sep 6, 2022

Hodgkin Lymphoma, Non Hodgkin Lymphoma Trial in United States (AB-205, Placebo)

Recruiting
  • Hodgkin Lymphoma
  • Non Hodgkin Lymphoma
  • AB-205
  • Placebo
  • Duarte, California
  • +20 more
Aug 2, 2022

Hematologic Malignancy, AML, ALL Trial in Australia, United States (Tagraxofusp, Fludarabine, Cytarabine)

Not yet recruiting
  • Hematologic Malignancy
  • +10 more
  • Los Angeles, California
  • +28 more
Jul 26, 2022

Hodgkin Lymphoma Trial in New York (Mocetinostat Plus Brentuximab Vedotin)

Completed
Has Results
  • Hodgkin Lymphoma
  • Mocetinostat Plus Brentuximab Vedotin
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 10, 2022

Multiple Myeloma, Hodgkin Lymphoma, Non-Hodgkin Lymphoma Trial in United States (Romiplostim)

Active, not recruiting
  • Multiple Myeloma
  • +3 more
  • Basking Ridge, New Jersey
  • +6 more
Mar 7, 2022

Hodgkin Lymphoma, Non-hodgkin Lymphoma Trial in United States (AB-205)

Completed
  • Hodgkin Lymphoma
  • Non-hodgkin Lymphoma
  • AB-205
  • Duarte, California
  • +8 more
Mar 1, 2022

Hodgkin Lymphoma Trial in Canada, United States (doxorubicin, Bleomycin, vinblastine)

Recruiting
  • Hodgkin Lymphoma
  • Detroit, Michigan
  • +9 more
Feb 16, 2022

Acute Lymphoid Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML) Trial in New York (radiation, drug,

Active, not recruiting
  • Acute Lymphoid Leukemia (ALL)
  • +5 more
  • Hyperfractionated total body irradiation
  • +9 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 21, 2022

Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt's Lymphoma Trial in United States (Haploidentical Bone Marrow

Completed
Has Results
  • Acute Lymphocytic Leukemia
  • +6 more
  • Haploidentical Bone Marrow Transplant
  • Double Umbilical Cord Blood Transplant
  • Birmingham, Alabama
  • +38 more
Nov 2, 2021

Hodgkin Lymphoma Trial in United States (brentuximab vedotin, nivolumab)

Completed
Has Results
  • Hodgkin Lymphoma
  • Duarte, California
  • +12 more
Nov 3, 2021

Hodgkin Lymphoma, Non-Hodgkin Lymphoma Trial in United Kingdom, United States (Camidanlumab tesirine)

Completed
Has Results
  • Hodgkin Lymphoma
  • Non-Hodgkin Lymphoma
  • Camidanlumab tesirine
  • Duarte, California
  • +11 more
Jul 12, 2021

Hematological Malignancy, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia in Remission Trial in New York (Cord blood

Completed
  • Hematological Malignancy
  • +5 more
  • Cord blood stem cells
  • +5 more
  • New York, New York
    Icahn School of Medicine at Mount Sinai
May 20, 2021

Lymphoid Malignancies, Lymphoma, Hodgkin Lymphoma Trial in New York (Romidepsin, Oral 5-Azacitidine)

Terminated
  • Lymphoid Malignancies
  • +3 more
  • New York, New York
    Columbia University Medical Center
Jan 5, 2021

Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma Trial in New York, Vancouver, Toronto (Brentuximab Vedotin, Bendamustine,

Completed
  • Hodgkin Lymphoma
  • Anaplastic Large Cell Lymphoma
  • Brentuximab Vedotin
  • +2 more
  • New York, New York
  • +2 more
Jul 15, 2020

Hodgkin Lymphoma Trial in United States (PLX3397)

Completed
Has Results
  • Hodgkin Lymphoma
  • Los Angeles, California
  • +5 more
Jun 18, 2020

Lymphoid Malignancies, Multiple Myeloma, Lymphoma Trial in Boston, New York (Pralatrexate, Romidepsin)

Unknown status
  • Lymphoid Malignancies
  • +4 more
  • Boston, Massachusetts
  • +1 more
Feb 6, 2020

Hodgkin Lymphoma Trial in United States (Atezolizumab)

Terminated
Has Results
  • Hodgkin Lymphoma
  • Basking Ridge, New Jersey
  • +5 more
Nov 12, 2019

Hodgkin Lymphoma Trial in New York, Houston, Seattle (Idelalisib)

Completed
Has Results
  • Hodgkin Lymphoma
  • New York, New York
  • +2 more
Oct 19, 2018

Positron-Emission Tomography, Immunomodulation, Metastatic Solid Malignancies Trial in Scottsdale, New York, Philadelphia

Completed
  • Positron-Emission Tomography
  • +3 more
  • ⁸⁹Zr-Df-IAB22M2C Infusion
  • Scottsdale, Arizona
  • +2 more
Sep 17, 2018

Hodgkin Lymphoma Trial in United States (Everolimus (RAD001))

Completed
Has Results
  • Hodgkin Lymphoma
  • Everolimus (RAD001)
  • Los Angeles, California
  • +15 more
Apr 18, 2016

Hodgkin Lymphoma, Non-Hodgkin Lymphoma (Follicular or Large Diffuse B-cell Lymphoma or Mantle Cell Lymphoma) Trial in United

Terminated
  • Hodgkin Lymphoma
  • Non-Hodgkin Lymphoma (Follicular or Large Diffuse B-cell Lymphoma or Mantle Cell Lymphoma)
  • MGCD0103 and Azacitidine
  • Beech Grove, Indiana
  • +3 more
Jun 4, 2015

Hodgkin Lymphoma, Mantle Cell Lymphoma, Indolent Lymphoma Trial in Canada, United States (SB1518)

Completed
  • Hodgkin Lymphoma
  • +2 more
  • Omaha, Nebraska
  • +4 more
Apr 19, 2012